Privo’s cutting-edge PRV platform technology is a culmination of 12 years of research and development at MIT’s prestigious Bob Langer Lab and Privo’s own R&D facility. Our platform stands at the forefront of innovation, offering revolutionary solutions aimed to redefine drug delivery and therapeutic effectiveness.
Innovative Platform Attributes:
1. Nanoparticles (NPs)
Privo’s Nanoparticles are at the core of our technology, providing a sophisticated solution for encapsulating Active Pharmaceutical Ingredients (APIs). These nanoparticles serve a dual purpose by not only safeguarding volatile drugs but also facilitating controlled sustained release, leading to enhanced cell uptake. Our NP technology ensures the precise delivery of therapeutic agents, maximizing their efficacy while minimizing adverse effects.
Our Matrix technology incorporates Generally Recognized as Safe (GRAS) excipients, playing a pivotal role in defining the dosage form for Privo’s drug products. Whether it’s injectables, patches, or hydrogels, Privo’s Matrix ensures the optimal delivery system for a diverse range of drugs. The versatility of the matrix empowers pharmaceutical professionals to tailor formulations that meet specific patient needs and optimize treatment outcomes.
2. Permeation Enhancer
Privo’s proprietary Permeation Enhancer is a game-changer in achieving uniform drug distribution and penetration throughout tissue. This technology ensures that therapeutic agents reach their target sites effectively, overcoming barriers that may hinder optimal drug delivery.
The Privo Advantage
- Expertise and Collaboration:
Backed by a rich heritage of research and collaboration with MIT’s Bob Langer Lab, Privo combines academic excellence with industry experience. Our team of experts has dedicated over a decade to perfecting the clinically validated PRV platform, ensuring that it meets and exceeds the evolving needs of the pharmaceutical industry.
- Innovation for Impact:
Privo is committed to pushing the boundaries of what is possible in drug delivery. Our platform technology is designed not only to improve the efficacy of existing drugs but also to pave the way for the development of novel therapeutics.
- Customized Solutions:
Privo understands that each drug has unique requirements. Our platform’s modular design allows for customization, empowering pharmaceutical professionals to tailor formulations to the specific needs of their therapies. This flexibility sets Privo apart, offering a level of adaptability that is essential in the rapidly advancing field of pharmaceuticals.
The PRV™ system is currently used for locoregional treatment of cancerous tumors. Additional formulations and treatment strategies comprising compounds for indications outside of oncology are under development, with promising results.
The proprietary manufacturing processes implemented in our in-house GMP facility allows Privo to produce and develop PRV-based therapeutics and scale production to meet clinical needs.
Partner with us
– Mahatma Gandhi